Viewing nowSapoem Sustained-Release Tablets 300 mg (Sarpogrelate Hydrochloride)
Sarpogrelate Hydrochloride 200mg
Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.

MFDS item code 201903493 · Approved 2019.05.28 · Insurance code 648603780
Improvement of ischemic symptoms such as ulcers and pain due to chronic arterial occlusion
This medication is used to improve ischemic symptoms such as ulcers, pain, and cold sensations caused by chronic arterial occlusion. It particularly helps relieve peripheral blood circulation disorders caused by Buerger's disease, obstructive atherosclerosis, and diabetic peripheral vascular disease. Improvement of these symptoms can enhance the quality of life of patients.
Sarpogrelate Hydrochloride sustained-release tablet 300 mg is administered orally once daily after meals. This medication should be taken whole, not chewed or crushed.
This medication should not be used in patients with bleeding as it may increase the risk of bleeding. It is safe to avoid administering to individuals with bleeding disorders such as hemophilia, gastrointestinal ulcers, or hemoptysis, as well as pregnant women or women who may become pregnant. Women on their menstrual period, patients with tendencies to bleed, or those taking anticoagulants or antiplatelet agents should use it with caution as the risk of bleeding may be increased. Patients with severely impaired kidney function and the elderly should also exercise caution when using this drug. During treatment, various adverse reactions such as urticaria, dyspepsia, diarrhea, headache, cough, and changes in blood pressure may occur, and if any symptoms arise, they should be reported immediately. Gastrointestinal bleeding, cerebral hemorrhage, blood disorders, and liver dysfunction may rarely occur; therefore, regular blood tests and health monitoring are important. The risk of bleeding may be increased when taken with anticoagulants or antiplatelet agents, so caution is needed when used in combination. It is advisable for pregnant or nursing women to avoid this medication as it may affect the fetus and newborn; if it is absolutely necessary, breastfeeding should be avoided. Safety in children has not been confirmed, so it is best not to use it in pediatric patients.
Urticaria, severe swelling (edema), chest tightness, difficulty breathing, liver problems (jaundice), severe skin reactions, bleeding (gastrointestinal bleeding, cerebral bleeding, subcutaneous bleeding), agranulocytosis, anemia, thrombocytopenia, leukopenia, acute hepatitis, liver impairment, acute liver failure, jaundice, respiratory difficulty, severe edema, increased blood pressure, confusion of consciousness, paralysis, myocardial infarction, stroke, cerebral infarction, acute lymphadenitis, renal impairment deterioration, pneumonia,
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, avoid storing in extremely hot or cold places, and it is recommended to keep it at room temperature between 1°C and 30°C.
White rectangular film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSarpogrelate Hydrochloride 200mg
Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Yuhan Corporation

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
(Co., Ltd.) Pharmgen Science

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Dongkook Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Haewon Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Allico Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.